FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Study: Januvia plays well with metformin


Free newsletter via e-mail
Tools

Merck's new diabetes drug Januvia delivered good blood sugar control over two years of treatment in combination with the older drug metformin, according to a new study the company is touting at the European Associaiton for the Study of Diabetes meeting. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.